Pathology | Test value | P value | Sig. | ||
---|---|---|---|---|---|
Non-muscle invasive | Muscle invasive | ||||
No. = 12 | No. = 31 | ||||
Location of lesions | |||||
Neck | 0 (0.0%) | 2 (6.5%) | 0.812* | 0.368 | NS |
Trigone | 1 (8.3%) | 3 (9.7%) | 0.019* | 0.892 | NS |
Dome | 1 (8.3%) | 5 (16.1%) | 0.438* | 0.508 | NS |
Anterior wall | 1 (8.3%) | 4 (12.9%) | 0.176* | 0.675 | NS |
Posterior wall | 3 (25.0%) | 1 (3.2%) | 4.862* | 0.027 | S |
Lateral walls | 4 (33.3%) | 16 (51.6%) | 1.162* | 0.281 | NS |
Circumferential | 0 (0.0%) | 5 (16.1%) | 2.190* | 0.139 | NS |
Ureteral orifice | 1 (8.3%) | 3 (9.7%) | 0.019* | 0.892 | NS |
Size | |||||
< 3 cm | 6 (50.0%) | 5 (16.1%) | 5.213* | 0.022 | S |
≥ 3 cm | 6 (50.0%) | 26 (83.9%) | |||
Tumor contact length (TCL) (cm) | |||||
Median (IQR) | 2.9 (1.65–3.75) | 5 (3.8–7.6) | − 2.682 ≠ | 0.007 | HS |
Range | 1.4–8.2 | 1.1–16 | |||
Stalk | |||||
No | 2 (16.7%) | 30 (96.8%) | 29.162* | 0.000 | HS |
Yes | 10 (83.3%) | 1 (3.2%) | |||
ADC value (× 10−3 mm2/s) | |||||
Mean ± SD | 1.03 ± 0.28 | 1.03 ± 0.23 | 0.028• | 0.978 | NS |
Range | 0.68–1.7 | 0.59–1.5 | |||
T stage | |||||
< T3 | 12 (100.0%) | 1 (3.2%) | 38.412* | 0.000 | HS |
≥ T3 | 0 (0.0%) | 30 (96.8%) |